Consonance Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,645,113
Closed -$131M 28
2018
Q4
$131M Buy
6,645,113
+2,766,063
+71% +$49.3M 9.61% 2
2018
Q3
$68.7M Buy
3,879,050
+669,850
+21% +$13.1M 3.7% 16
2018
Q2
$69.1M Buy
+3,209,200
New +$66.4M 4.45% 10

Other funds holding EXEL

Consonance Capital Management's EXEL Position: Q1 2019 in Review

Consonance Capital Management sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 6,645,113 shares — an estimated $131M sold.

Consonance Capital Management first reported a position in EXEL in Q2 2018 and held it in 3 quarters. The position peaked at $131M in Q4 2018. 378 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

  • Consonance Capital Management reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
  • Consonance Capital Management sold 6,645,113 Exelixis shares in Q1 2019, an estimated $131M.
  • Consonance Capital Management first reported a position in Exelixis in Q2 2018 and held it in 3 quarters.
  • Consonance Capital Management's Exelixis position peaked at $131M in Q4 2018.
  • 378 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on Consonance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.